THE ESSENCE OF ARRHYTHMIA

Finding the essence of any arrhythmia is the key to make a difference in each patient's life. With our unique solutions, physicians are now able to derive and execute an individual and optimized ablation strategy for every patient.

EP Topics

Back to home

PEER-TO-PEER VIDEOS

Get insights into the latest studies and experiences when using charge density non-contact mapping. Our peer-to-peer platform offers various videos from renown experts in electrophysiology. Register for free and get access to all these talk - from Prof. Betts to Prof. Boldt and Prof. Boersma.

Ablation for persistent atrial fibrillation – the new core-to-boundary strategy

The mechanisms sustaining persistent atrial fibrillation (perAF) are still a hot topic in electrophysiology and cardiology in general. Recent randomized trials demonstrate that pulmonary vein isolation (PVI) alone achieves outcomes similar to those of more extensive ablation strategies in treating perAF.¹

EHRA CONGRESS 2021: THE FUTURE OF EP PRACTICE – RESTREAM THE BIOTRONIK AND ACUTUS MEDICAL JOINT SESSION

The annual scientific meeting of the European Heart Rhythm Association just took place digitally and brought numerous interesting presentations, live cases and discussions by renowned experts with it. To join the discussion about the Future of EP Practice watch the joint session of BIOTRONIK and ACUTUS Medical.

ATRIAL FIBRILLATION 2020 ESC GUIDELINE UPDATE: BETTER CARE IS NOW “AS SIMPLE AS ABC”

Recently, the European Society of Cardiology (ESC) has updated its guidelines for the diagnosis and treatment of atrial fibrillation (AF). A lot of emphasis was placed on the “CC-ABC” strategy. Here are the most important changes for electrophysiology experts.

How a fast map-ablate-remap strategy influences therapy and procedures

Despite improvements in technology over the years, ablation treatments of atrial fibrillation (AF) are still very time consuming – often taking more time and resources than they should. There is a need for optimized ablation strategies that not only improve clinical outcomes, but also allow for shorter procedure times and therefore a higher number of procedures being done in a more cost-effective way.

How do therapies benefit from contact force in complex AF procedures?

Use of contact force catheters during ablation of AF has led to a reduction of acute PV reconnection and fewer gaps in the circumferential isolation lines and has significantly improved clinical outcome after AF ablation. Consistent stable tip-tissue contact is needed to increase the safety of the procedure and will prevent the creation of transmural lesions and reduce the potential of recurring AF.

PLANNING FOR THE CHALLENGES AND EP THERAPIES OF VARIABLE AND TRANSIENT RHYTHMS

Today, more AF patients with complex atrial substrates are being offered ablation. This leads to the need for optimized ablation strategies that make it easy for healthcare practitioners to adapt to increasingly complex cases of AF. Understanding patient-specific, non-pulmonary vein mechanisms in persistent AF is one of the essential components in establishing effective ablation strategies that improve clinical outcomes.

HOW IS AN INDIVIDUALIZED THERAPY POSSIBLE GIVEN HIGH PRESSURE ON WORKFLOW?

Individualized therapy as an integral component Even under especially challenging circumstances, such as the COVID-19 pandemic, individualized therapy is still an integral component of the work of electrophysiology (EP) departments. Technological advances help to ensure that patient-specific procedures can be performed quickly and efficiently in spite of changed hospital routines.

CHALLENGES FOR ELECTROPHYSIOLOGY DURING AND AFTER THE COVID-19 PANDEMIC

Daily routines in most hospitals changed dramatically. Every hand was needed to provide medical care for COVID-19 patients or to prepare for their arrival. To protect patients and staff from COVID-19 exposure, it was necessary to postpone all non-urgent or non-emergent electrophysiological procedures¹, especially because arrhythmias are an additional health risk with COVID-19.